<DOC>
	<DOC>NCT00584766</DOC>
	<brief_summary>To determine the therapeutic efficacy of high-dose cyclophosphamide and BCNU with autologous bone marrow transplantation after initial tumor cytoreduction for patients with receptor-negative metastatic breast carcinoma and to determine the optimal timing of CyBCNU-ABMT after initial development of metastatic breast carcinoma</brief_summary>
	<brief_title>Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>breast carcinoma at first clinical evidence of metastatic disease must have measurable disease by physical exam, xray, or scan Age &lt; or equal to 55 performance status 02 can't have had more than one prior chemotherapy regimen can't have had concurrent hormonal therapy no brain metastases no previous pelvic radiation no history of another malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>